These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18166880)

  • 21. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Directly Mailing gFOBT Kits to Previous Responders Being Recalled for Colorectal Cancer Screening Increases Participation.
    Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle CC; Levitt C; Lu Y; MacKinnon M; Paszat L; Rabeneck L
    J Can Assoc Gastroenterol; 2020 Oct; 3(5):197-203. PubMed ID: 32905094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to colorectal cancer screening in an HMO population.
    Myers RE; Trock BJ; Lerman C; Wolf T; Ross E; Engstrom PF
    Prev Med; 1990 Sep; 19(5):502-14. PubMed ID: 2235919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advance notification letters increase adherence in colorectal cancer screening: a population-based randomized trial.
    van Roon AH; Hol L; Wilschut JA; Reijerink JC; van Vuuren AJ; van Ballegooijen M; Habbema JD; van Leerdam ME; Kuipers EJ
    Prev Med; 2011 Jun; 52(6):448-51. PubMed ID: 21457725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Participants' characteristics in a French colorectal cancer mass screening campaign.
    Herbert C; Launoy G; Thezee Y; Maurel J; Richir B; Reaud JM; Ollivier V; Pegulu L; Valla A; Gignoux M
    Prev Med; 1995 Sep; 24(5):498-502. PubMed ID: 8524725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies for increasing participation in mail-out colorectal cancer screening programs: a systematic review and meta-analysis.
    Goodwin BC; Ireland MJ; March S; Myers L; Crawford-Williams F; Chambers SK; Aitken JF; Dunn J
    Syst Rev; 2019 Nov; 8(1):257. PubMed ID: 31685010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From the bench to public health: population-level implementation intentions in colorectal cancer screening.
    Neter E; Stein N; Barnett-Griness O; Rennert G; Hagoel L
    Am J Prev Med; 2014 Mar; 46(3):273-80. PubMed ID: 24512866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
    Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
    Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
    Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A
    Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cost-effectiveness analysis on colorectal cancer screening program].
    Huang QC; Ye D; Jiang XY; Li QL; Yao KY; Wang JB; Jin MJ; Chen K
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):65-68. PubMed ID: 28100379
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost-Effectiveness Analysis of a Navigation Program for Colorectal Cancer Screening to Reduce Social Health Inequalities: A French Cluster Randomized Controlled Trial.
    De Mil R; Guillaume E; Guittet L; Dejardin O; Bouvier V; Pornet C; Christophe V; Notari A; Delattre-Massy H; De Seze C; Peng J; Launoy G; Berchi C
    Value Health; 2018 Jun; 21(6):685-691. PubMed ID: 29909873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score.
    Sekiguchi M; Igarashi A; Sakamoto T; Saito Y; Esaki M; Matsuda T
    J Gastroenterol Hepatol; 2020 Sep; 35(9):1555-1561. PubMed ID: 32167186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France.
    Berchi C; Bouvier V; Réaud JM; Launoy G
    Health Econ; 2004 Mar; 13(3):227-38. PubMed ID: 14981648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening with faecal occult blood test (FOBT) for colorectal cancer: assessment of two methods that attempt to improve compliance.
    Ore L; Hagoel L; Lavi I; Rennert G
    Eur J Cancer Prev; 2001 Jun; 10(3):251-6. PubMed ID: 11432712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer.
    Lejeune C; Arveux P; Dancourt V; Béjean S; Bonithon-Kopp C; Faivre J
    Int J Technol Assess Health Care; 2004; 20(4):434-9. PubMed ID: 15609792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of mailing fecal occult blood test kits on return rate in a community cancer screening center.
    Mahon SM
    Oncol Nurs Forum; 1995 Sep; 22(8):1259-63. PubMed ID: 8532551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies for delivery of faecal occult blood test kits and participation to colorectal cancer screening in the Emilia-Romagna Region of Italy.
    Mancini S; Ravaioli A; Falcini F; Giuliani O; Corradini R; De Girolamo G; Goldoni CA; Finarelli AC; Naldoni C; Landi P; Sassoli de Bianchi P; Bucchi L
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28032381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians.
    Ransohoff DF; Lang CA
    Ann Intern Med; 1997 May; 126(10):811-22. PubMed ID: 9148658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
    Ladabaum U; Mannalithara A
    Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preliminary results of a mass screening program for colorectal cancer].
    Bedenne L; Durand G; Faivre J; Milan C; Boutron MC; Arveux P; Colombier P; Klepping C
    Gastroenterol Clin Biol; 1990; 14(2):140-5. PubMed ID: 2328881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.